Rite Aid, which discloses Q3 results on Wednesday, is expected to swing to a 2-cent per-share loss vs. EPS of 2 cents in the prior-year period, while revenue is seen sliding 4% to $7.74 billion. Pharmacy stocks took a walloping back in October on talk that Amazon could enter the pharma space, but Walgreens, Rite Aid and CVS Health (CVS) have since retaken support at their 50-day lines.